Stitcher for Podcasts

Get the App Open App
Bummer! You're not a
Stitcher Premium subscriber yet.
Learn More
Start Free Trial
$4.99/Month after free trial

Show Info

Episode Info

Episode Info: The finish line for the vaccine race is just around the corner. Terry and Dr. Bob react to vaccine developments and respond to ICER’s recent attacks. Plus, the second part of our interview with Dr. Robert Popovian gives us the latest on Operation War Speed, President Trump’s executive orders and the impact on drug costs for patients. And Kate brings us an inside look at a clinical trial from participant Ian Haydon. Guest:Robert Popovian, PharmD.VP of U.S. Government Relations, Pfizer Inc. Robert Popovian is currently Vice President, U.S. Government Relations at Pfizer Inc. where he leads the advocacy function in the U.S. Robert brings over two decades of experience in numerous facets of the biopharmaceutical and health care industry with a strong track record of expertise in Health Care Policy and Economics, Government Relations, Medical Affairs, and Strategic Planning.Robert has published and presented extensively on the impact of biopharmaceuticals and health policies on health care costs and clinical outcomes, including authorship in clinical and healthcare delivery journals, and is a published expert source in First Word, The Hill, Los Angeles Times, USA Today, Pink Sheet, Managed Healthcare Executive and Bloomberg News amongst many others.He also writes a regularly published column in Morning Consult regarding health policy and economic issues relevant to the biopharmaceutical industry. He is a frequent speaker at healthcare policy and medical conferences on topics such as payment and delivery reform, pricing, reimbursement, biosimilars, biopharmaceutical innovation, and health economics. He currently serves on the Board of Councilors of the University of Southern California, School of Pharmacy and Board of Advisors for Capital RX.He is one of the few researchers who has studied and published both clinical and policy related economic analysis as well as one of a handful who have studied and published empirical data regarding emerging payment models in the U.S. healthcare system and for biopharmaceutical reimbursement. He also was one of the first to secure inclusion of health outcomes data regarding labeled indication of a biopharmaceutical.Robert completed his Doctorate in Pharmacy and Master of Science in Pharmaceutical Economics and Policy degrees at the University of Southern California with honors. He also has completed a residency in Pharmacy Practice/Adult Internal Medicine and Infectious Diseases at the Los Angeles County – University of Southern California Hospital and a fellowship in Pharmaceutical Economics and Policy at University of Southern California.Robert is married to Maylin Megran Popovian. They have two daughters, Katrina and Natalya. They have residences both in Los Angeles, CA and Washington, DC.Hosts:Terry Wilcox, Executive Director, Patients RisingDr. Robert Goldberg, “Dr. Bob”, Co-Founder and Vice President of the Center for Medicine in the Public Interest.Kate Pecora, Field Correspondent Links...
Read more »

Discover more stories like this.

Like Stitcher On Facebook


Episode Options

Listen Whenever

Similar Episodes

Related Episodes